Analysis of potential biomarkers and immune infiltration in autism based on bioinformatics analysis

Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder caused by both environmental and genetic factors. However, its etiology and pathogenesis remain unclear. The purpose of this study was to establish an immune-related diagnostic model for ASD using bioinformatics methods and to identify ASD biomarkers. Two ASD datasets, GSE18123 and GSE29691, were integrated into the gene expression Database to eliminate batch effects. 41 differentially expressed genes were identified by microarray data linear model (limma package). Based on the results of the immune infiltration analysis, we speculated that neutrophils, B cells naive, CD8+ T cells, and Tregs are potential core immune cells in ASD and participate in the occurrence of ASD. Finally, the differential genes and immune infiltration in ASD and non-ASD patients were compared, and the most relevant genes were selected to construct the first immune correlation prediction model of ASD. After the calculation, the model exhibited better accuracy. The calculations show that the model has good accuracy.

[1]  W. Nour-Eldine,et al.  In search of immune cellular sources of abnormal cytokines in the blood in autism spectrum disorder: A systematic review of case-control studies , 2022, Frontiers in Immunology.

[2]  D. Siniscalco,et al.  Immune Dysregulation in Autism Spectrum Disorder: What Do We Know about It? , 2022, International journal of molecular sciences.

[3]  H. Al Dera.  Cellular and molecular mechanisms underlying autism spectrum disorders and associated comorbidities: A pathophysiological review. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[4]  S. Rogers,et al.  Dysregulated gene expression associated with inflammatory and translation pathways in activated monocytes from children with autism spectrum disorder , 2022, Translational Psychiatry.

[5]  K. Manley,et al.  Constitutive activation of Notch signalling and T cell activation characterize a mouse model of autism , 2022, Cell biochemistry and function.

[6]  A. Nadeem,et al.  Imbalance in pro-inflammatory and anti-inflammatory cytokines milieu in B cells of children with autism. , 2021, Molecular immunology.

[7]  Kelly A. Shaw,et al.  Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2018 , 2021, Morbidity and mortality weekly report. Surveillance summaries.

[8]  Yasong Du,et al.  Rescue of maternal immune activation-induced behavioral abnormalities in adult mouse offspring by pathogen-activated maternal Treg cells , 2021, Nature Neuroscience.

[9]  Sayyed Ali Samadi,et al.  Living under psychosocial pressure: Perception of mothers of children with autism spectrum disorders. , 2021, Journal of child and adolescent psychiatric nursing : official publication of the Association of Child and Adolescent Psychiatric Nurses, Inc.

[10]  Kejin Hu,et al.  Become Competent within One Day in Generating Boxplots and Violin Plots for a Novice without Prior R Experience , 2020, Methods and protocols.

[11]  Jie Wu,et al.  A nomogram for predicting overall survival in patients with low‐grade endometrial stromal sarcoma: A population‐based analysis , 2020, Cancer communications.

[12]  E. Zhao,et al.  A signature of 14 immune-related gene pairs predicts overall survival in gastric cancer , 2020, Clinical and Translational Oncology.

[13]  Enfa Zhao,et al.  Identification of Differentially Expressed Genes Associated with Idiopathic Pulmonary Arterial Hypertension by Integrated Bioinformatics Approaches , 2020, J. Comput. Biol..

[14]  A. Nadeem,et al.  Elevated expression of toll-like receptor 4 is associated with NADPH oxidase-induced oxidative stress in B cells of children with autism. , 2020, International immunopharmacology.

[15]  A. Nadeem,et al.  Dysregulation in IL-6 receptors is associated with upregulated IL-17A related signaling in CD4+ T cells of children with autism , 2020, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[16]  H. Stevens,et al.  Chronic maternal interleukin-17 and autism-related cortical gene expression, neurobiology, and behavior , 2020, Neuropsychopharmacology.

[17]  Mai Moaaz,et al.  Th17/Treg cells imbalance and their related cytokines (IL-17, IL-10 and TGF-β) in children with autism spectrum disorder , 2019, Journal of Neuroimmunology.

[18]  Fadi Thabtah,et al.  Early Autism Screening: A Comprehensive Review , 2019, International journal of environmental research and public health.

[19]  E. Glaab,et al.  Transcriptome profiling data reveals ubiquitin-specific peptidase 9 knockdown effects , 2019, Data in brief.

[20]  A. Nadeem,et al.  Oxidative and inflammatory mediators are upregulated in neutrophils of autistic children: Role of IL-17A receptor signaling , 2019, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[21]  A. Nadeem,et al.  Dysregulated enzymatic antioxidant network in peripheral neutrophils and monocytes in children with autism , 2019, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[22]  J. Constantino,et al.  Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2012 , 2018, Morbidity and mortality weekly report. Surveillance summaries.

[23]  T. van Amelsvoort,et al.  Immune aberrations in children with Autism Spectrum Disorder: a case-control study from a tertiary care neuropsychiatric hospital in India , 2018, Psychoneuroendocrinology.

[24]  Z. Warren,et al.  Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2010. , 2014, Morbidity and mortality weekly report. Surveillance summaries.

[25]  K. Hozyasz,et al.  Immune Abnormalities in Autism Spectrum Disorder—Could They Hold Promise for Causative Treatment? , 2018, Molecular Neurobiology.

[26]  A. Grigoryan,et al.  Advances in understanding the pathophysiology of autism spectrum disorders , 2017, Behavioural Brain Research.

[27]  T. Theoharides,et al.  Mast cells, brain inflammation and autism. , 2016, European journal of pharmacology.

[28]  Graham M Lord,et al.  IL-10-produced by human transitional B-cells down-regulates CD86 expression on B-cells leading to inhibition of CD4+T-cell responses , 2016, Scientific Reports.

[29]  Hossein Baharvand,et al.  DDX3Y, a Male-Specific Region of Y Chromosome Gene, May Modulate Neuronal Differentiation. , 2015, Journal of proteome research.

[30]  Ash A. Alizadeh,et al.  Robust enumeration of cell subsets from tissue expression profiles , 2015, Nature Methods.

[31]  L. Cantley,et al.  Idelalisib--a PI3Kδ inhibitor for B-cell cancers. , 2014, The New England journal of medicine.

[32]  Z. Trajanoski,et al.  Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. , 2013, Immunity.

[33]  D. Amaral,et al.  Myeloid dendritic cells frequencies are increased in children with autism spectrum disorder and associated with amygdala volume and repetitive behaviors , 2013, Brain, Behavior, and Immunity.

[34]  A. Depino.  Peripheral and central inflammation in autism spectrum disorders , 2013, Molecular and Cellular Neuroscience.

[35]  S. Chasovskikh,et al.  α-Synuclein Alters Toll-Like Receptor Expression , 2011, Front. Neurosci..

[36]  H. Gendelman,et al.  Nitrated α-Synuclein-Induced Alterations in Microglial Immunity Are Regulated by CD4+ T Cell Subsets1 , 2009, The Journal of Immunology.

[37]  J. Gregg,et al.  Altered gene expression and function of peripheral blood natural killer cells in children with autism , 2009, Brain, Behavior, and Immunity.

[38]  Paula Krakowiak,et al.  Decreased transforming growth factor beta1 in autism: A potential link between immune dysregulation and impairment in clinical behavioral outcomes , 2008, Journal of Neuroimmunology.

[39]  R. Doyle,et al.  Autism, gut-blood-brain barrier, and mast cells. , 2008, Journal of clinical psychopharmacology.

[40]  Konstantinos Francis,et al.  Novel therapeutic targets for autism. , 2008, Trends in pharmacological sciences.

[41]  P. Conti,et al.  Differential release of mast cell mediators and the pathogenesis of inflammation , 2007, Immunological reviews.

[42]  Shimon Sakaguchi,et al.  Foxp3+CD25+CD4+ natural regulatory T cells in dominant self‐tolerance and autoimmune disease , 2006, Immunological reviews.

[43]  R. Locksley,et al.  Helper T cells regulate type-2 innate immunity in vivo , 2002, Nature.

[44]  I. Homma,et al.  Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. , 2002, Immunity.

[45]  N. Abbott.  Inflammatory Mediators and Modulation of Blood–Brain Barrier Permeability , 2000, Cellular and Molecular Neurobiology.

[46]  P. Scott,et al.  Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice , 1993, The Journal of experimental medicine.

[47]  C. Hsieh,et al.  Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. , 1993, Science.

[48]  Allyson L Dailey.  Metabolomic Bioinformatic Analysis. , 2017, Methods in molecular biology.

[49]  Tanya Barrett,et al.  The Gene Expression Omnibus Database , 2016, Statistical Genomics.

[50]  Shimon Sakaguchi,et al.  Regulatory T cells exert checks and balances on self tolerance and autoimmunity , 2010, Nature Immunology.

[51]  T. Theoharides,et al.  Corticotropin-releasing hormone and the blood-brain-barrier. , 2007, Frontiers in bioscience : a journal and virtual library.